UCF Spinout firm Nano Discovery Wins 2015 TechConnect Innovation Award for New Cancer Detection Screening Using Gold Nano Particles

Orlando, Fla. --  Nano Discovery, Inc. has been named a 2015 TechConnect Innovation Award winner.  Only the top 20 percent of the hundreds of technologies submitted were selected to receive awards at the recent TechConnect 2015 Innovation Summit in Washington, D.C.

Dr. Treen Huo, CEO, showcased Nano Discovery’s blood test for early detection of cancer and autoimmune diseases before an audience of potential investors and licensing partners.  The company is seeking additional funding to further test its process and as well as partners to commercialize the procedure. 

Nano Discovery’s invention utilizes about a dollar’s worth of microscopic gold particles to detect early signs of cancer in the blood. With a simple finger prick and some sophisticated testing equipment, Nano Discovery’s test takes just a few moments.  The test is significantly more reliable than the standard early screening for cancers such as prostate cancer which currently is screened using the Protein Specific Antigen test (PSA).  Nano Discovery’s testing process is proving effective at identifying cancer cells much earlier than most existing tests. 

The lower cost and ease of administration mean the testing procedure could be done in a doctor’s office or pharmacy.  Those factors along with the high degree of accuracy mean the procedure could save literally millions of lives by detecting the presence of cancer cells early on when treatment is most effective.

Nano Discovery is a client company of the UCF Business Incubation Program Central located at Central Florida Research Park in East Orange County.